These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1824849)

  • 1. Targeting human cytotoxic T lymphocytes to kill heterologous epidermal growth factor receptor-bearing tumor cells. Tumor-infiltrating lymphocyte/hormone receptor/recombinant antibody.
    Gillies SD; Wesolowski JS; Lo KM
    J Immunol; 1991 Feb; 146(3):1067-71. PubMed ID: 1824849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated redirected cytolysis against murine melanoma cells in vivo.
    Usuba O; Ito M; Bona CA; Moran TM
    Cancer Res; 1990 Sep; 50(18):6034-8. PubMed ID: 2144210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of in vitro tumor-infiltrating lymphocyte cytotoxicity by heteroconjugated antibodies.
    Reid I; Lundy J; Donohue JH
    J Immunol; 1992 Apr; 148(8):2630-5. PubMed ID: 1532818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.
    Garrido MA; Valdayo MJ; Winkler DF; Titus JA; Hecht TT; Perez P; Segal DM; Wunderlich JR
    Cancer Res; 1990 Jul; 50(14):4227-32. PubMed ID: 2142014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature requirements and kinetics of T cell signaling. Velocity of triggering correlates with functional effects of anti-CD3 mAb.
    Abdi K; Reed ML; Mentzer SJ; Herrmann SH
    J Immunol; 1989 May; 142(9):2971-80. PubMed ID: 2468707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced in vitro lysis of human ovarian carcinomas with activated peripheral blood lymphocytes and bifunctional immune heteroaggregates.
    Donohue JH; Ramsey PS; Kerr LA; Segal DM; McKean DJ
    Cancer Res; 1990 Oct; 50(20):6508-14. PubMed ID: 2145062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
    Quinones RR; Segal DM; Henkart P; Perez P; Gress RE
    J Immunol; 1989 Apr; 142(7):2200-6. PubMed ID: 2466891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.
    De Jong R; Brouwer M; Rebel VI; Van Seventer GA; Miedema F; Van Lier RA
    Immunology; 1990 Jul; 70(3):357-64. PubMed ID: 2143171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway.
    Scott CF; Lambert JM; Kalish RS; Morimoto C; Schlossman SF
    J Immunol; 1988 Jan; 140(1):8-14. PubMed ID: 2891767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes.
    Kerr L; Huntoon C; Donohue J; Leibson PJ; Bander NH; Ghose T; Luner SJ; Vessella R; McKean DJ
    J Immunol; 1990 May; 144(10):4060-7. PubMed ID: 2139677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis.
    Leo O; Sachs DH; Samelson LE; Foo M; Quinones R; Gress R; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3874-80. PubMed ID: 3097135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes.
    Massaro AF; Schoof DD; Rubinstein A; Zuber M; Leonard-Vidal FJ; Eberlein TJ
    Cancer Res; 1990 May; 50(9):2587-92. PubMed ID: 2139356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.
    Hoffman RW; Quinones RR; Shaw S
    Behring Inst Mitt; 1985 Aug; (77):30-8. PubMed ID: 3936472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized monovalent CD3 antibody which can activate homologous complement.
    Routledge EG; Lloyd I; Gorman SD; Clark M; Waldmann H
    Eur J Immunol; 1991 Nov; 21(11):2717-25. PubMed ID: 1834468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
    Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
    Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.